DOI QR코드

DOI QR Code

DENTAL MANAGEMENT OF A PATIENT WITH MOYAMOYA DISEASE UNDER GENERAL ANESTHESIA

모야모야병(moyamoya disease) 환자의 전신마취 하 치과 치료

  • Sang, Eun Jung (Dept. of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Song, Ji-Soo (Dept. of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Shin, Teo Jeon (Dept. of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Kim, Young-Jae (Dept. of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Kim, Jung-Wook (Dept. of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Jang, Ki-Taeg (Dept. of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Lee, Sang-Hoon (Dept. of Pediatric Dentistry, School of Dentistry, Seoul National University) ;
  • Hyun, Hong-Keun (Dept. of Pediatric Dentistry, School of Dentistry, Seoul National University)
  • 상은정 (서울대학교 치의학대학원 소아치과학교실) ;
  • 송지수 (서울대학교 치의학대학원 소아치과학교실) ;
  • 신터전 (서울대학교 치의학대학원 소아치과학교실) ;
  • 김영재 (서울대학교 치의학대학원 소아치과학교실) ;
  • 김정욱 (서울대학교 치의학대학원 소아치과학교실) ;
  • 장기택 (서울대학교 치의학대학원 소아치과학교실) ;
  • 이상훈 (서울대학교 치의학대학원 소아치과학교실) ;
  • 현홍근 (서울대학교 치의학대학원 소아치과학교실)
  • Received : 2017.09.24
  • Accepted : 2017.11.27
  • Published : 2017.12.30

Abstract

Moyamoya disease is a disorder in which certain arteries in the brain are constricted. Blood flow can be blocked by the constriction and blood clots. The patients frequently experience transient ischemic attacks (TIA), cerebral hemorrhage, or may not experience any symptoms at all. It is reported that they have a higher risk of recurrent stroke and a distinct underlying pathophysiology. A 3-year-8-month old boy with moyamoya disease experienced cerebral infarctions five times, and he underwent a cerebrovascular anastomosis surgery four years ago. He showed swallow disturbance, general delayed development, hemiplegia, and strabismus. Also he had hypocalcified teeth with or without multiple caries lesions in all dentitions. Dental treatment under general anesthesia using sevoflurane was performed due to his lack of cooperation. Moyamoya disease is associated with various medical conditions requiring a thoughtful deliberation and a careful examination before and during dental treatment. Pain and anxiety control during dental treatment is important because hyperventilation induced by crying has been seen to trigger TIA. Both isoflurane and sevoflurane are commonly used in patients with MMD, but dynamic autoregulation is better preserved during sevoflurane than isoflurane anesthesia. So sevoflurance general anesthesia may be recommendable to manage dental patients having multiple caries with moyamoya disease.

MMD 환자는 심한 울음이나 운동 등으로 유발되는 과호흡성 뇌혈류량 감소에 주의해야 하며, 특히 소아 환자의 경우 낯선 환경에서 쉽게 울음을 터뜨리는 경향이 있고, 뇌의 산소요구량이 많으며, 뇌혈류량 변화에 민감하므로 치과 진료 시에 더욱 세심한 관리가 필요하다. 본 증례는 발달 지연을 동반하여 일상의 구강 위생 관리 및 치과 검진에 비협조적이고, 다수 치아에 광범위한 우식증을 보이는 발달장애가 있는 MMD 소아 환자를 전신 마취 하에 안전하고 효과적으로 치료한 사항을 보고하는 바이다. 환아는 이전에 수차례의 뇌경색 증상을 보여 뇌혈관 문합술을 받은 바 있고, 발달 지연 외에도 지적 장애, 언어장애, 편마비, 연하장애, 사시증을 동반하였다. 환아의 기저 질환과 협조도, 우식의 심도를 고려하여 세보플루레인을 이용한 전신 마취를 행동조절 요법으로 선택하였고, 술 전 정맥로 확보 시 환아의 불안을 조절하기 위해 미다졸람 경구 투여를 시행하였다. 모든 생징후를 안전하게 감시하며 성공적으로 치과 치료를 마친 후, 적극적인 통증 조절을 위해 아세트아미노펜 경구 투여를 시행하였다. 전신마취 이후에는 정기 검진 및 불소 도포를 통해 환자의 구강 건강 증진에 기여할 수 있었다.

Keywords

References

  1. Bang OY, Fujimura M, Kim SK : The Pathophysiology of Moyamoya Disease: An Update. J Stroke, 18:12-20, 2016. https://doi.org/10.5853/jos.2015.01760
  2. Kamada F, Aoki Y, Kure S, et al. : A genomewide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet, 56: 34-40, 2011. https://doi.org/10.1038/jhg.2010.132
  3. Kim EH, Yum MS, Yoo HW, et al. : Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease. J Neurosurg, 124:1221-1227, 2016. https://doi.org/10.3171/2015.4.JNS142900
  4. Suzuki J, Takaku A. : Cerebrovascular" moyamoya" disease : Disease showing abnormal net-like vessels in base of brain. Arch Neurol, 20:288-299, 1969. https://doi.org/10.1001/archneur.1969.00480090076012
  5. Wakai K, Tamakoshi A, Ohno Y, et al. : Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol neurosurg, 99:S1-S5, 1997. https://doi.org/10.1016/S0303-8467(97)00031-0
  6. Oh CW : Neuroimaging Diagnosis and Treatment of Moyamoya Disease. J Korean Med Assoc, 48: 179-188, 2005. https://doi.org/10.5124/jkma.2005.48.2.179
  7. Imaizumi T, Hayashi K, Fukuyama Y, et al. : Long-Term Outcomes of Pediatric Moyamoya Disease Monitored to Adulthood. Pediatr Neurol, 18:321-325, 1998. https://doi.org/10.1016/S0887-8994(97)00209-9
  8. Kurokawa T, Tomita S, Kitamura K, et al. : Prognosis of Ocdusive Disease of the Circle of Willis (Moyamoya disease) in Children, Pediat Neurol, 1:274-277, 1985. https://doi.org/10.1016/0887-8994(85)90027-X
  9. Lee CK, Kim JG, Lee DW, Yang YM : Treatment of openbite with myofunctional therapy in moyamoya disease patient. J Korean Dis Oral Health, 13:19-22, 2017.
  10. Parray T, Martin TW, Siddiqui S : Moyamoya Disease: A Review of the Disease and Anesthetic Management. J Neurosurg Anesthesiol, 23:100-109, 2011. https://doi.org/10.1097/ANA.0b013e3181f84fac
  11. Nomura S, Kashiwagi S, Ito H, et al. : Perioperative management protocols for children with moyamoya disease. Childs Nerv Syst, 17:270-274, 2001. https://doi.org/10.1007/s003810000407
  12. Miller CL, Alexander K, Griffiths R, et al. : Local Cerebral Blood Flow Following Transient Cerebral Ischemia. II. Effect of Arterial Pco2 on Reperfusion Following Global Ischemia. Stroke, 11:542-548, 1980. https://doi.org/10.1161/01.STR.11.5.542
  13. Kansha M, Irita K, Takahashi S, Matsushima T : Anesthetic management of children with Moyamoya disease. Clin Neurol Neurosurg, 99: S110-S113, 1997.
  14. Soriano SG, Sethna NF, Scott RM : Anesthetic Management of Children with Moyamoya Syndrome. Anesth Analg, 77:1066-1070, 1993.
  15. Summors AC, Gupta AK, Matta BF : Dynamic Cerebral Autoregulation During Sevoflurane Anesthesia: A Comparison with Isoflurane. Anesth Analg, 88:341-345, 1999.
  16. Tagawa T, Naritomi H, Sawada T, et al. : Regional Cerebral Blood Flow, Clinical Manifestations, and Age in Children With Moyamoya Disease. Stroke, 18:906-910, 1987. https://doi.org/10.1161/01.STR.18.5.906